NCT02227888View on ClinicalTrials.gov

PK Study of N91115 in Cystic Fibrosis Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Cystic Fibrosis
Interventions
DRUG

N91115

S nitrosoglutathione reductase inhibitor

Trial Locations (3)

35294

University of Alabama @ Birmingham, Birmingham

80045

Children's CO, Aurora

80206

National Jewish Health, Denver

Sponsors
All Listed Sponsors
lead

Nivalis Therapeutics, Inc.

INDUSTRY

NCT02227888 - PK Study of N91115 in Cystic Fibrosis Patients | Biotech Hunter | Biotech Hunter